1[1]Serrano, M. The INK4a/ARF locus in murine tumorigenesis.Carcinogenesis, 2000, 21: 865~869.
2[2]Bringold F, Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol, 2000, 35: 317~329.
3[3]Serrano M, Hannon G J, Beach D. A new regulatory motif in cell cycle control cousing specific inhibition of cyclinD/CDK4. Nature,1993, 336: 704~707.
4[4]Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types.Science, 1994, 264: 436~440.
5[5]Nobori, T, Miura K, Wu DJ, et al. Deletions of the cyclindependent kinnase-4 inhibitor gene in multiple human cancers.Nature, 1994, 368: 753~756.
6[6]Quell DE, Zindy F, Ashmun RA, et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell arrest. Cell, 1995, 83 (6): 993~1000.
7[7]Haber, DA. Splicing into senescence: The curious case of P16 and P19ARF. Cell, 1977, 91 (5): 555~558.
8[8]Shapiro GI, Edwards CD, Kobcik I, et al. Reciporcal RB inactivation and P16INK4expression in primary lung cancers and cell lines. Cancer Res, 1995, 55 (3): 505~509.
9[9]Pomerant J, Schreiber-Agus N, Liegeois NJ, et al. The INK4a tumor supperssor gene product, P19ARF, interacts with MDM2 and neutrailizes MDM2's inhibition of P53. Cell, 1998, 92 (6); 713~723.
10[10]Kurokawa K, Tanaka T, Kalo J. P19ARFprevents G1 cyclindependent kinase activation by interacting with MDM2 and activiating P53 in mouse fibroblasts. Oncogene, 1999, 18 (17):2718~2727.